People
It was a busy week for biotech quarterly and annual reports. Here’s a look at some of the top stories including Bristol-Myers Squibb, AbbVie, GSK, Merck and more.
This morning, San Diego-based Illumina, Inc. announced that Gottlieb joined its board of directors effective Feb. 4.
Pharma and biotech companies strengthen their leadership teams and boards with this weeks appointments.
One day after GlaxoSmithKline began to outline some of the broad strokes of splitting the company into two separate entities, more details are coming into place – particularly staffing concerns over the integration of the company’s vaccine business into its pharma operations.
Findacure co-founder will apply extensive drug repurposing and rare disease expertise to progress Healx’s drug candidates into the clinic.
Chants of “H.R. 3” broke out in the House of Representatives chamber during Tuesday night’s State of the Union Address as Democratic lawmakers urged action on the bill passed late last year that could impact the price of prescription medications paid for by government-funded health programs.
BryoLogyx Inc., announced that David Crockford has joined the Company as vice president of clinical development and logistics, a new position.
Pappas Capital, a leading investor in early-stage life sciences companies, has appointed Karen LeVert as Venture Partner to help lead the expansion of the firm’s Specialized Fund Management business, with a focus on identifying attractive investment opportunities in agricultural and other related technologies.
PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has made two appointments to strengthen its leadership team, as the Company positions itself for growth.
Polarean Imaging plc announces that Jonathan Allis, Non-Executive Director, has assumed the role of Chairman with immediate effect.
PRESS RELEASES